| Year |
Citation |
Score |
| 2017 |
Hudzik TJ, Basso AM, Lynch JJ, Bracken WM, Mohler EG, Kohlhaas KL, Xu H, Haig G, Gault L. Preclinical abuse liability assessment of ABT-126, an agonist at the α7 nicotinic acetylcholine receptor (nAChR). Pharmacology, Biochemistry, and Behavior. PMID 28579351 DOI: 10.1016/J.Pbb.2017.05.010 |
0.331 |
|
| 2013 |
Brown JW, Whitehead CA, Basso AM, Rueter LE, Zhang M. Preclinical evaluation of non-imidazole histamine H3 receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 889-904. PMID 22906530 DOI: 10.1017/S1461145712000739 |
0.413 |
|
| 2012 |
Baker S, Chin CL, Basso AM, Fox GB, Marek GJ, Day M. Xanomeline modulation of the blood oxygenation level-dependent signal in awake rats: development of pharmacological magnetic resonance imaging as a translatable pharmacodynamic biomarker for central activity and dose selection. The Journal of Pharmacology and Experimental Therapeutics. 341: 263-73. PMID 22267203 DOI: 10.1124/Jpet.111.188797 |
0.312 |
|
| 2011 |
Zhang M, Ballard ME, Basso AM, Bratcher N, Browman KE, Curzon P, Konno R, Meyer AH, Rueter LE. Behavioral characterization of a mutant mouse strain lacking D-amino acid oxidase activity. Behavioural Brain Research. 217: 81-7. PMID 20933022 DOI: 10.1016/J.Bbr.2010.09.030 |
0.422 |
|
| 2010 |
Basso AM, Curzon P, Zhang M, Gallagher KB, Salte K, Brown J, Nikkel AL, Bitner RS, Day M, Decker MW, Fox GB, Rueter LE, Chin C. NEONATAL TREATMENT WITH METHYLAZOXYMETHANOL ACETATE (MAM) AS A NEURODEVELOPMENTAL MODEL OF SCHIZOPHRENIA: BEHAVIORAL, PHARMACOLOGICAL AND MORPHOLOGICAL CHARACTERIZATION Schizophrenia Research. 117: 272-273. DOI: 10.1016/J.Schres.2010.02.437 |
0.328 |
|
| 2009 |
Basso AM, Bratcher NA, Harris RR, Jarvis MF, Decker MW, Rueter LE. Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders. Behavioural Brain Research. 198: 83-90. PMID 18996151 DOI: 10.1016/j.bbr.2008.10.018 |
0.338 |
|
| 2007 |
Ballard ME, Basso AM, Gallagher KB, Browman KE, Fox GB, Drescher KU, Gross G, Decker MW, Rueter LE, Zhang M. The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment. Psychopharmacology. 190: 1-11. PMID 17093979 DOI: 10.1007/S00213-006-0577-Y |
0.413 |
|
| 2006 |
Basso AM, Bratcher NA, Gallagher KB, Cowart MD, Zhao C, Sun M, Esbenshade TA, Brune ME, Fox GB, Schmidt M, Collins CA, Souers AJ, Iyengar R, Vasudevan A, Kym PR, et al. Lack of efficacy of melanin-concentrating hormone-1 receptor antagonists in models of depression and anxiety. European Journal of Pharmacology. 540: 115-20. PMID 16765941 DOI: 10.1016/J.Ejphar.2006.04.043 |
0.302 |
|
| 2005 |
Basso AM, Gallagher KB, Bratcher NA, Brioni JD, Moreland RB, Hsieh GC, Drescher K, Fox GB, Decker MW, Rueter LE. Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1257-68. PMID 15688083 DOI: 10.1038/sj.npp.1300677 |
0.354 |
|
| 2004 |
Rueter LE, Ballard ME, Gallagher KB, Basso AM, Curzon P, Kohlhaas KL. Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophrenia. Psychopharmacology. 176: 312-9. PMID 15179541 DOI: 10.1007/s00213-004-1897-4 |
0.302 |
|
| 2002 |
Baldo BA, Sadeghian K, Basso AM, Kelley AE. Effects of selective dopamine D1 or D2 receptor blockade within nucleus accumbens subregions on ingestive behavior and associated motor activity. Behavioural Brain Research. 137: 165-77. PMID 12445722 DOI: 10.1016/S0166-4328(02)00293-0 |
0.575 |
|
| 1999 |
Basso AM, Spina M, Rivier J, Vale W, Koob GF. Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology. 145: 21-30. PMID 10445369 DOI: 10.1007/s002130051028 |
0.337 |
|
| 1999 |
Basso AM, Kelley AE. Feeding induced by GABA(A) receptor stimulation within the nucleus accumbens shell: regional mapping and characterization of macronutrient and taste preference. Behavioral Neuroscience. 113: 324-36. PMID 10357457 DOI: 10.1037/0735-7044.113.2.324 |
0.503 |
|
| 1998 |
Kelley AE, Baldwin AE, Basso AM, Stratford TR. EXCITATORY AMINO ACID PSYCHOPHARMACOLOGY OFTHE NUCLEUS ACCUMBENS CORE AND SHELL Behavioural Pharmacology. 9: S48. DOI: 10.1097/00008877-199808000-00098 |
0.538 |
|
| Show low-probability matches. |